James R Rodrigue
Overview
Explore the profile of James R Rodrigue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1642
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez R, Mohan S, Rodrigue J, Arrigain S, Brosi D, Lavanchy R, et al.
Am J Transplant
. 2025 Jan;
PMID: 39855342
No abstract available.
2.
Lopez R, Mohan S, Rodrigue J, Arrigain S, Brosi D, Lavanchy R, et al.
Am J Transplant
. 2024 Nov;
PMID: 39608573
Under 2020 Centers for Medicare and Medicaid Services (CMS) conditions of coverage, Organ Procurement Organizations (OPOs) will be decertified if their 95% upper confidence limit for donation or transplant rate...
3.
Rodrigue J, Schold J, Glazier A, Mone T, Hasz R, Dils D, et al.
Crit Care Med
. 2024 Sep;
52(12):1877-1884.
PMID: 39283196
Objectives: To conduct a contemporary analysis of the association between family approach of medically suitable potential organ donors and race/ethnicity. Design: Retrospective review of data collected prospectively by Organ Procurement...
4.
Taber D, Su Z, Gebregziabher M, Mauldin P, Morinelli T, Mahmood A, et al.
J Am Coll Surg
. 2023 Feb;
236(4):721-727.
PMID: 36728400
Background: African Americans (AAs) have reduced access to kidney transplant (KTX). Our center undertook a multilevel quality improvement endeavor to address KTX access barriers, focused on vulnerable populations. This program...
5.
Rodrigue J, Shenkel J, Boger M, Pomahac B, Fleishman A
Transplant Direct
. 2022 Oct;
8(10):e1355.
PMID: 36204186
Methods: Participants (n = 556) were randomized to 1 of 3 VCA video messaging interventions (informational, testimonial, or blended), a general (non-VCA) organ donation video message, or a control (nondonation)...
6.
Sokas C, Ali Husain S, Xiang L, King K, Mohan S, Salim A, et al.
J Am Coll Surg
. 2022 Jun;
234(6):1075-1081.
PMID: 35703800
Background: Management of patients on the kidney transplant waitlist lacks oversight, and transplant centers can delist candidates without consequence. To better understand between-center differences in waitlist management, we examined delisting...
7.
Cohen S, Cowan V, Rohan V, Pavlakis M, Curry M, Adler J, et al.
J Surg Res
. 2022 Jun;
278:342-349.
PMID: 35667277
Introduction: Transplantation of organs exposed to hepatitis C virus (HCV) into uninfected patients has yielded excellent outcomes and more widespread adoption may lead to fewer discarded organs and more transplants....
8.
Adler J, Ali Husain S, Xiang L, Rodrigue J, Waikar S
Kidney360
. 2022 May;
3(3):488-496.
PMID: 35582180
Background: The 240,000 rural patients with end stage kidney disease in the United States have less access to nephrology care and higher mortality than those in urban settings. The Advancing...
9.
Harris D, Fleishman A, Pavlakis M, Pollak M, Baliga P, Rohan V, et al.
J Surg Res
. 2022 Apr;
277:116-124.
PMID: 35489216
Introduction: The discovery of apolipoprotein L1 (ApoL1) has raised important ethical and clinical questions about genetic testing in the context of living and deceased kidney donation. Largely missing from this...
10.
Morinelli T, Taber D, Su Z, Rodrigue J, Sutton Z, Chastain M, et al.
Prog Transplant
. 2021 Dec;
32(1):27-34.
PMID: 34874194
The optimal treatment for end-stage kidney disease is renal transplant. However, only 1 in 5 (21.5%) patients nationwide receiving dialysis are on a transplant waitlist. Factors associated with patients not...